Correction: MacCuaig et al. Toxicity Assessment of Mesoporous Silica Nanoparticles upon Intravenous Injection in Mice: Implications for Drug Delivery. Pharmaceutics 2022, 14, 969

Key Points

• To assess the toxicity of mesoporous silica nanoparticles following intravenous injection in mice.
• Assessment of toxicity effects after intravenous administration of nanoparticles in mice.
• Comparison of physiological responses to mesoporous silica nanoparticles.
• Analysis of potential implications for drug delivery systems.
• Observed toxicity levels indicate significant safety concerns in various physiological systems.
• Findings suggest a need for careful evaluation of nanoparticle formulations for drug delivery.